• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Comprehensive Overview of 4-Bromo-N,N-dimethyl-1H-pyrrolo[2,3-b]pyridine-3-methanamine (CAS No. 1198277-82-5)

4-Bromo-N,N-dimethyl-1H-pyrrolo[2,3-b]pyridine-3-methanamine (CAS No. 1198277-82-5) is a brominated heterocyclic compound with a molecular formula of C10H12BrN3. This specialized chemical has garnered significant attention in pharmaceutical and agrochemical research due to its unique pyrrolopyridine scaffold, which is a privileged structure in drug discovery. The compound's N,N-dimethyl substitution and bromo functional group enhance its reactivity, making it a valuable intermediate for synthesizing bioactive molecules.

Researchers are increasingly exploring 4-Bromo-N,N-dimethyl-1H-pyrrolo[2,3-b]pyridine-3-methanamine for its potential applications in kinase inhibitor development, particularly in oncology and neurodegenerative disease research. Its structural similarity to ATP-competitive kinase binding motifs has made it a focal point in small molecule drug design. Recent publications highlight its utility in creating targeted therapies, aligning with the growing demand for precision medicine approaches.

The compound's pyrrolo[2,3-b]pyridine core is particularly noteworthy, as this bicyclic system demonstrates excellent pharmacokinetic properties in drug candidates. Pharmaceutical chemists value this scaffold for its balanced lipophilicity and hydrogen bonding capacity, which are crucial for blood-brain barrier penetration – a hot topic in CNS drug development. This characteristic makes CAS No. 1198277-82-5 particularly interesting for researchers working on Alzheimer's and Parkinson's disease treatments.

From a synthetic chemistry perspective, the bromo substituent at the 4-position offers versatile transformation opportunities through cross-coupling reactions. This feature has become increasingly important with the rise of Pd-catalyzed reactions in medicinal chemistry. The compound serves as an excellent substrate for Suzuki, Buchwald-Hartwig, and other modern coupling methodologies that dominate current pharmaceutical process chemistry.

Analytical characterization of 4-Bromo-N,N-dimethyl-1H-pyrrolo[2,3-b]pyridine-3-methanamine typically involves advanced techniques such as LC-MS, NMR spectroscopy (1H, 13C), and HPLC purity analysis. These methods are essential for quality control in preclinical research and have become standard practice in modern chemical development workflows. The compound's stability profile under various conditions is another area of active investigation, particularly for researchers optimizing formulation strategies.

In the context of green chemistry initiatives, there's growing interest in developing more sustainable synthetic routes to pyrrolopyridine derivatives. This aligns with broader industry trends toward environmentally friendly synthesis and reduced waste generation. The electron-rich nature of CAS No. 1198277-82-5 makes it amenable to photocatalytic transformations, an emerging area in green pharmaceutical synthesis.

The compound's potential extends beyond human therapeutics into agrochemical applications. Its structural features are being evaluated for developing novel crop protection agents, particularly as the agricultural industry seeks alternatives to traditional pesticides. This dual applicability in pharma and agro sectors makes 4-Bromo-N,N-dimethyl-1H-pyrrolo[2,3-b]pyridine-3-methanamine a compound of significant commercial interest.

Recent patent literature reveals innovative uses of this brominated heterocycle in material science applications, particularly in organic electronics. Its conjugated system and ability to participate in charge transfer complexes are being explored for developing organic semiconductors – a rapidly growing field driven by demand for flexible electronics and sustainable technologies.

For researchers sourcing this compound, proper storage conditions and handling protocols are essential to maintain its stability. While not classified as hazardous under standard regulations, best practices recommend protection from light and moisture, reflecting general chemical stewardship principles that are becoming industry standards.

The future research directions for 4-Bromo-N,N-dimethyl-1H-pyrrolo[2,3-b]pyridine-3-methanamine likely include exploration of its enantioselective transformations and development of continuous flow synthesis methods. These approaches address current priorities in process intensification and chiral drug development, making CAS No. 1198277-82-5 a compound with enduring relevance in chemical research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)